rs113806080
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 3P and 16B. PM1PP3BP4_StrongBP6_Very_StrongBS2
The NM_005609.4(PYGM):c.2009C>T(p.Ala670Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00419 in 1,614,162 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A670A) has been classified as Likely benign.
Frequency
Consequence
NM_005609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PYGM | NM_005609.4 | c.2009C>T | p.Ala670Val | missense_variant | 17/20 | ENST00000164139.4 | |
PYGM | NM_001164716.1 | c.1745C>T | p.Ala582Val | missense_variant | 15/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PYGM | ENST00000164139.4 | c.2009C>T | p.Ala670Val | missense_variant | 17/20 | 1 | NM_005609.4 | P1 | |
PYGM | ENST00000377432.7 | c.1745C>T | p.Ala582Val | missense_variant | 15/18 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00427 AC: 650AN: 152188Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00490 AC: 1231AN: 251412Hom.: 9 AF XY: 0.00481 AC XY: 654AN XY: 135896
GnomAD4 exome AF: 0.00419 AC: 6119AN: 1461856Hom.: 22 Cov.: 32 AF XY: 0.00413 AC XY: 3003AN XY: 727228
GnomAD4 genome AF: 0.00427 AC: 650AN: 152306Hom.: 3 Cov.: 32 AF XY: 0.00536 AC XY: 399AN XY: 74482
ClinVar
Submissions by phenotype
Glycogen storage disease, type V Benign:6
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 14, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 21, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 14, 2021 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 11, 2014 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | PYGM: PP3, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2019 | This variant is associated with the following publications: (PMID: 24503134, 20108426, 33111339) - |
PYGM-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at